Medication info
Parabezol Tablet 10 mg (Rabeprazole Sodium)

Parabezol Tablet 10 mg (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Dasan Pharmaceutical Co., Ltd.
Appearance
Yellowish round enteric-coated tablets
Packaging
28 tablets (14 tablets/Alu Alu packaging x 2)
Approval status
Active

MFDS item code 201902206 · Approved 2019.04.11 · Insurance code 678601260

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric and duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this drug 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g, twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, and the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.
Child dose
Safety in children has not been established.

Ingredients

Manufacturer
Dasan Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including use in combination for eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease
  • peptic ulcer
  • Zollinger-Ellison syndrome
View approved original text

This medication is used to treat peptic ulcers such as gastric ulcers and duodenal ulcers. It also alleviates symptoms of erosive or ulcerative gastroesophageal reflux disease and assists in the maintenance therapy for gastroesophageal reflux disease that requires long-term treatment. In patients infected with Helicobacter pylori, it enhances therapeutic efficacy when used in combination with antibiotics. Additionally, it is effective in conditions associated with excessive gastric acid production, such as Zollinger-Ellison syndrome. It is utilized to improve various gastrointestinal-related diseases.

How to take

Adult dose

Gastric and duodenal ulcers The usual adult dose is 10 mg of rabeprazole sodium orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally given for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition has not healed after 8 weeks of treatment with a proton pump inhibitor (PPI), 10 mg or 20 mg may be administered orally twice daily for an additional 8 weeks. However, 20 mg twice daily is for patients with confirmed severe mucosal damage only. Relief of symptoms of gastroesophageal reflux disease Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is necessary. After symptoms resolve, subsequent symptoms may be controlled using on-demand therapy with 10 mg once daily as needed. Long-term maintenance therapy for gastroesophageal reflux disease Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication It is recommended that this drug 20 mg be administered concomitantly with clarithromycin 500 mg and amoxicillin 1 g, twice daily for 7 days. Zollinger-Ellison syndrome The recommended initial adult dose is 60 mg once daily. The dose may be adjusted up to 120 mg daily according to the individual patient's needs. Doses up to 100 mg may be administered once daily, and the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this drug for up to 1 year.

Child dose

Safety in children has not been established.

Precautions

This medication should not be administered to certain patients. For instance, individuals with allergies to this medication or its components, or those with a history of hypersensitivity should avoid use. Caution is also required when used in combination by individuals allergic to penicillin or macrolide antibiotics. It is advisable that pregnant or breastfeeding women do not take this medication. Patients with liver function issues, the elderly, or those with a history of drug hypersensitivity should use this medication with caution. Allergic reactions such as skin rashes, itching, or hives may occur while taking this medication; if such symptoms arise, users should immediately discontinue use. Regular blood tests are necessary as blood tests may show changes in red or white blood cell counts. Since it may affect liver function, regular liver function tests are required due to possible elevated liver enzyme levels or symptoms such as hepatitis and jaundice. Various abnormal reactions like cardiac symptoms, blood pressure changes, gastrointestinal symptoms, and neurological symptoms have been reported, so users should be attentive to their health conditions. As this medication suppresses gastric acid secretion, long-term use may increase the risk of bone fractures and lead to electrolyte imbalances such as hypomagnesemia. Therefore, regular monitoring of magnesium levels is important during prolonged use. This medication can interact with other drugs; therefore, especially when taken with antibiotics, antivirals, or anticoagulants, consultation with a doctor or pharmacist is necessary. Do not chew or crush the tablets; swallow them whole, and keep them out of reach of children. If any abnormal symptoms occur, it is important to consult with a professional immediately.

Side effects

Rash, hives, itching, decreased red blood cells, decreased white blood cells, increased white blood cells, increased eosinophils, increased neutrophils, decreased lymphocytes, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, ventricular tachycardia, thrombophlebitis, vasodilation, QTc prolongation, ventricular fibrillation, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcers, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, dry mouth, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, taste disorders, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland swelling, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory disturbance, tremors, weakness, hyperesthesia, drowsiness, vertigo, depression, restlessness, amnesia, confusion, extrapyramidal syndrome, hypervolemia, upper and lower limb weakness, sensory numbness, reduced grip strength, language confusion, staggering, disorientation, spatial disorientation, hypersomnia, cough, pharyngitis, rhinitis, shortness of breath, asthma, nosebleeds, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, muscle hypertonia, neuralgia, single contraction, sweating, alopecia, dry skin, herpes zoster, psoriasis, skin color changes, toxic epidermal necrolysis, mucous membrane syndrome, erythema multiforme, cataracts, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blurred vision, double vision, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, frequency of urination, dysmenorrhea, urinary difficulty, kidney stones, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, orchitis, urinary incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, loss of appetite, neck stiffness, photosensitive reactions, hangover effects, weight loss, gout, anaphylactic reactions, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reactions, arthralgia, idiopathic renal inflammation, gynecomastia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucous membrane syndrome, increased INR, prolonged prothrombin time, bone fractures, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, cutaneous lupus erythematosus, halitosis, dry mouth, allergic reactions, tightness in the chest, hypertriglyceridemia, hypercholesterolemia, palpitations, increased intraocular pressure, facial edema, flushing, tingling in hands and feet, confusion, weakness, insomnia, drowsiness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a tightly sealed container. Additionally, to maintain the medication's effectiveness, it is important to store it at a temperature between 1°C and 30°C.

Appearance and packaging

Appearance

Yellowish round enteric-coated tablets

Package unit

28 tablets (14 tablets/Alu Alu packaging x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.